Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.20.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities:    
Net loss $ (12,705) $ (12,038)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization of debt discounts 1,389 0
Stock-based compensation 958 105
Expense related to common stock issued in settlements 922 112
Depreciation and amortization 66 58
Change in foreign currency translation from closure of subsidiary 48 0
Amortization of intangible asset 28 33
Change in fair value of warrant liability (16) (204)
Loss on disposal of property and equipment 0 2
Expense for the issuance of warrants and common stock for services 0 310
Change in fair value of derivative liability 0 171
Change in fair value of common stock warrants upon repricing 0 892
Changes in operating assets and liabilities:    
Accounts receivable 23 4
Inventories (42) (1,283)
Prepaid expenses and other assets 89 (516)
Accounts payable (882) 1,022
Accrued liabilities 263 300
Net cash used in operating activities (9,859) (11,032)
Cash flows from investing activities:    
Proceeds from sale of property and equipment 0 1
Purchases of property and equipment (52) (35)
Net cash used in investing activities (52) (34)
Cash flows from financing activities:    
Proceeds from issuance of common stock, prefunded warrants and warrants, net of issuance costs 6,240 6,149
Proceeds from issuance of common stock, net of issuance costs 9,916 0
Proceeds from the issuance of preferred stock and common stock warrants, net of issuance costs 0 920
Proceeds from the exercise of prefunded warrants and common stock warrants, net of issuance costs 789 1,167
Proceeds from issuance of promissory notes 847 0
Proceeds from issuance of convertible notes payable, net of issuance costs 1,396 0
Repayment of convertible notes payable (2,151) 0
Repayment of capital lease (9) 0
Taxes paid related to net share settlements of equity awards 0 (87)
Net cash provided by financing activities 17,028 8,149
Effect of exchange rate changes on cash and cash equivalents 0 (3)
Net increase (decrease) in cash and cash equivalents 7,117 (2,920)
Cash and cash equivalents as of beginning of year 298 3,218
Cash and cash equivalents as of end of year 7,415 298
Supplemental disclosure of cash flow information:    
Cash paid for interest 352 0
Cash paid for income taxes 3 8
Noncash Investing and Financing Activities:    
Issuance of warrants in connection with common stock offerings 8,354 0
Issuance of warrants in connection with convertible notes payable 630 0
Warrant repricing 134 0
Deemed dividend from warrant repricing (134) 0
Convertible preferred stock dividend 80 56
Property and equipment purchased through capital lease 72 0
Issuance of common stock in connection with convertible notes payable 4 0
Issuance of common stock warrants in connection with preferred stock offering 0 243
Issuance of warrants in connection with public offering 0 97
Fair value of derivative liability in connection with issuance of convertible preferred stock $ 0 $ 216